Nalaganje...
Denosumab in Giant Cell Tumor of Bone: Current Status and Pitfalls
Denosumab is a monoclonal antibody against RANK ligand for treatment of giant cell tumor of bone (GCTB). Clinical trials and case series have demonstrated that denosumab is relevant to beneficial tumor response and surgical down-staging in patients of GCTB. However, these trials or case series have...
Shranjeno v:
| izdano v: | Front Oncol |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Frontiers Media S.A.
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7567019/ https://ncbi.nlm.nih.gov/pubmed/33123484 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.580605 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|